ArticleThe Laryngoscope2012

Preclinical validation of AR42, a novel histone deacetylase inhibitor, as treatment for vestibular schwannomas.

Abraham Jacob et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.